Trial Profile
Evaluation of GSK Biologicals' Boostrix(TM) in Healthy Adults, 10 Years After Previous Booster Vaccination
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Adverse reactions; Pharmacodynamics
- Sponsors GlaxoSmithKline
- 18 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Jun 2010 New trial record